Document Detail


Preventive effect of pravastatin sodium, a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on coronary atherosclerosis and xanthoma in WHHL rabbits.
MedLine Citation:
PMID:  3132979     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In this paper, we examined whether the development of atherosclerosis in the Watanabe heritable hyperlipidemic (WHHL) rabbit, an animal model of familial hypercholesterolemia in man, could be prevented by the reduction of serum cholesterol levels. Pravastatin sodium (the generic name of CS-514), a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, was used as a cholesterol-lowering drug. The drug was administered orally to 12 WHHL rabbits (2-3 months old) at a dose of 50 mg/kg per day for 24 weeks, and 13 animals were given water as control. In the treated group, serum cholesterol, phospholipid and triacylglycerol levels were significantly reduced by 28%, 32% and 16%, respectively, as compared with those of the control group. Although the prevention of development of the aortic atherosclerosis was not significant, the progression of coronary atherosclerosis was significantly prevented. The incidence of atherosclerosis in four main coronary arteries was reduced from 42% (control group) to 19% (treated group, P less than 0.01), and the development of lesion of coronary arteries evaluated by area of lesion was reduced from 19.7% (control group) to 9.1% (treated group, P less than 0.05). Histopathological findings supported the above observations. In addition, development of xanthoma in digital joints was also reduced from 90.4% (control group) to 58.3% (treated group, P less than 0.005). These results suggest that the development of coronary atherosclerosis and xanthoma in WHHL rabbit was reduced by continuous reduction of serum cholesterol levels treated with pravastatin sodium.
Authors:
Y Watanabe; T Ito; M Shiomi; Y Tsujita; M Kuroda; M Arai; M Fukami; A Tamura
Related Documents :
1156469 - Serum and aortic lipid profiles in spontaneous and cholesterol-induced atherosclerosis ...
3632759 - Promotion and regression of atherosclerosis in vervet monkeys by diets realistic for we...
17332479 - Chronic intermittent hypoxia induces atherosclerosis.
598459 - Relations between spontaneous and induced arterial lesions in swine and arteriosclerosi...
15302989 - Comparative effects of candesartan and amlodipine in a monkey atherosclerotic model.
20378019 - Circulating plasma antioxidants, inflammatory markers and asymptomatic carotid atherosc...
9500689 - Cholesterol metabolism and serum and biliary noncholesterol sterols in gallstone patien...
8462379 - Apolipoprotein e polymorphism is associated with plasma cholesterol response in a 7-day...
4352459 - Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and v...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Biochimica et biophysica acta     Volume:  960     ISSN:  0006-3002     ISO Abbreviation:  Biochim. Biophys. Acta     Publication Date:  1988 Jun 
Date Detail:
Created Date:  1988-07-29     Completed Date:  1988-07-29     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0217513     Medline TA:  Biochim Biophys Acta     Country:  NETHERLANDS    
Other Details:
Languages:  eng     Pagination:  294-302     Citation Subset:  IM    
Affiliation:
Institute for Experimental Animals, Kobe University School of Medicine, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Cholesterol / blood
Coronary Artery Disease / blood,  enzymology,  prevention & control*
Coronary Vessels / pathology
Heptanoic Acids / pharmacology*
Hydroxymethylglutaryl-CoA Reductase Inhibitors*
Lipids / blood
Naphthalenes / pharmacology*
Phospholipids / blood
Pravastatin
Rabbits
Xanthomatosis / prevention & control*
Chemical
Reg. No./Substance:
0/Heptanoic Acids; 0/Hydroxymethylglutaryl-CoA Reductase Inhibitors; 0/Lipids; 0/Naphthalenes; 0/Phospholipids; 57-88-5/Cholesterol; 81093-37-0/Pravastatin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Characterization and expression in Escherichia coli of an endoglucanase gene of Pseudomonas fluoresc...
Next Document:  Isolation and structural characterization of a diacyltaurolipid in cells of Tetrahymena mimbres.